Due to the absence of available p53 isogenic models for HNSCC, we used the isogenic HCT116 p53+/+ and HCT116 p53−/− model to more conclusively study the role of p53 loss. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.